Showing 1 - 10 of 33,544
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by …
Persistent link: https://www.econbiz.de/10010223101
manufacturer) on pharmaceutical regulation in a North-South framework with a firm's endogenous decision to export to the South … via reimbursement limits. Parallel trade may relax regulation in the source country of parallel imports (South) and … intensify regulation in the destination country (North): In the source country, parallel trade may relax regulation both under a …
Persistent link: https://www.econbiz.de/10011986314
The U.S. Food and Drug Administration (FDA) balances risks and benefits before approving pharmaceuticals, as … any given initial expected risk level, optimal risk-taking decisions involving uncertainty in a multi-period world should …
Persistent link: https://www.econbiz.de/10014148944
In this article we analyse the market for drugs in health care markets where third payers (an insurance company or a government agency) bear the cost and we suggest a common and transparent methodology to set the price for new drugs as well as active principles for which an alternative already...
Persistent link: https://www.econbiz.de/10014028693
One of the most difficult legal issues today involves settlements by which brand-name drug companies pay generic firms to delay entering the market. Such conduct requires courts to consider not only patent and antitrust law, but also the Hatch-Waxman Act, the complex regime governing behavior in...
Persistent link: https://www.econbiz.de/10013100789
efforts by international organizations, such as the World Trade Organization (WTO). Next, the paper considers patent incentive …
Persistent link: https://www.econbiz.de/10014077712
Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions between pharmaceutical firms and healthcare...
Persistent link: https://www.econbiz.de/10011586604
the pharmaceutical industry is the presence of price regulation in most countries. Taking into account the impact of …
Persistent link: https://www.econbiz.de/10012871310
This paper studies externalities of nationally determined cost-sharing systems, in particular coinsurance rates (patients pay a percentage of the price), under pharmaceutical parallel trade in a two-country model with a vertical distributor relationship. Parallel trade generates a...
Persistent link: https://www.econbiz.de/10012973688
schemes. While the intensity of regulation varies substantially among countries, lightly regulated markets are the exception …, particularly from an economic standpoint. In this regard, pharmaceuticals are not generally traded in what might be described as a … "free market" in the sense of absence of regulation, and this includes import restrictions which are generally consistent …
Persistent link: https://www.econbiz.de/10014124812